Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$566M |
| 2 |
Meta Platforms (Facebook)
META
|
+$401M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$366M |
| 4 |
Align Technology
ALGN
|
+$356M |
| 5 |
PayPal
PYPL
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
Alibaba
BABA
|
+$511M |
| 3 |
Altria Group
MO
|
+$439M |
| 4 |
Revvity
RVTY
|
+$321M |
| 5 |
Merck
MRK
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 9.61% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLR
1126
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $1.16M | ﹤0.01% |
94,389
+71,369
| +310% | +$1.16M |
|
1127
US Physical Therapy
USPH
$1.22B
| $1.14M | ﹤0.01% |
13,092
+1,099
| +9% | +$94.6K |
|
1128
Zions Bancorporation
ZION
$10.1B
| $1.13M | ﹤0.01% |
38,564
-463
| -1% | -$14.9K |
|
1129
CNA Financial
CNA
$14.9B
| $1.13M | ﹤0.01% |
37,505
-1,070
| -3% | -$34.5K |
|
1130
Molina Healthcare
MOH
$10.4B
| $1.12M | ﹤0.01% |
6,125
+877
| +17% | +$160K |
|
1131
United Airlines
UAL
$38.8B
| $1.11M | ﹤0.01% |
31,886
-171
| -0.5% | -$5.92K |
|
1132
Builders FirstSource
BLDR
$7.29B
| $1.08M | ﹤0.01% |
33,094
-13,798
| -29% | -$375K |
|
1133
UGI
UGI
$7.87B
| $1.07M | ﹤0.01% |
32,484
+3,007
| +10% | +$99.8K |
|
1134
Medifast
MED
$107M
| $1.07M | ﹤0.01% |
6,507
-3,204
| -33% | -$528K |
|
1135
AerCap
AER
$23.4B
| $1.06M | ﹤0.01% |
41,963
-142,193
| -77% | -$4.12M |
|
1136
NOV
NOV
$6.84B
| $1.04M | ﹤0.01% |
114,987
-21,119
| -16% | -$247K |
|
1137
Globant
GLOB
$1.65B
| $1.03M | ﹤0.01% |
5,759
-3,488
| -38% | -$601K |
|
1138
Vanguard Total International Bond ETF
BNDX
$82B
| $1.01M | ﹤0.01% |
17,330
-10,046
| -37% | -$583K |
|
1139
Franklin Resources
BEN
$16.8B
| $1M | ﹤0.01% |
49,398
+4,185
| +9% | +$87.9K |
|
1140
Invesco
IVZ
$12.4B
| $935K | ﹤0.01% |
81,919
-19,189
| -19% | -$203K |
|
1141
Avantor
AVTR
$9.73B
| $934K | ﹤0.01% |
41,572
+6,215
| +18% | +$129K |
|
1142
Trex
TREX
$4.4B
| $930K | ﹤0.01% |
12,988
-5,120
| -28% | -$354K |
|
1143
UFP Industries
UFPI
$4.95B
| $927K | ﹤0.01% |
16,409
-5,836
| -26% | -$329K |
|
|
MNRL
1144
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $909K | ﹤0.01% |
101,947
+10,444
| +11% | +$115K |
|
1145
Protolabs
PRLB
$1.7B
| $908K | ﹤0.01% |
7,011
-105,388
| -94% | -$13.9M |
|
1146
Parsons
PSN
$4.31B
| $906K | ﹤0.01% |
27,021
-9,942
| -27% | -$344K |
|
1147
Tactile Systems Technology
TCMD
$618M
| $905K | ﹤0.01% |
24,744
+1,670
| +7% | +$61.2K |
|
1148
Warrior Met Coal
HCC
$4.17B
| $898K | ﹤0.01% |
52,598
-7,119
| -12% | -$116K |
|
|
EFOR
1149
Everforth Inc
EFOR
$960M
| $895K | ﹤0.01% |
14,083
-5,235
| -27% | -$360K |
|
|
AGR
1150
DELISTED
Avangrid, Inc.
AGR
| $883K | ﹤0.01% |
17,500
+3,243
| +23% | +$156K |
|
Similar funds
Janus Henderson Group's Q3 2020 Portfolio in Review
As of Q3 2020, Janus Henderson Group held 1,403 positions worth $192B, up 7.7% from $178B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q3 2020 filing shows 105 new, 521 increased, 678 reduced and 86 closed positions. Its largest new stake was Acceleron Pharma: 1,783,939 shares worth $201M. The largest sale was Apple, an estimated $564M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2020 buy was Acceleron Pharma: 1,783,939 shares worth $201M.
- Janus Henderson Group added most to Booking.com in Q3 2020, an estimated $566M increase.
- Janus Henderson Group's biggest Q3 2020 reduction was Apple, cutting an estimated $564M.
- Janus Henderson Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $49.5M.
- Janus Henderson Group's ten largest holdings make up 24% of its $192B portfolio in Q3 2020.
- Janus Henderson Group opened 105 new positions and closed 86 in Q3 2020.
- Janus Henderson Group's portfolio value rose 7.7% quarter-over-quarter to $192B.
Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.